At a glance
- Originator Kyowa Hakko
- Class Anti-inflammatories; Antidepressants; Nitrobenzenes; Pyridines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 29 Dec 1994 Discontinued-I for Alzheimer's disease in Japan (Unknown route)